Inhibrx (INBX) Stock Highlights

13.39 | +1.9%

2025-02-17 06:31:37

Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates. The company has four programs in clinical trials, of which three of the programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency.

Statistics

Range Today

13.05 13.6

Volume Today 55.1K

Range 1 Year

10.8 39.79

Volume 1 Year 62.16M

Range 3 Year

7.67 39.79

Volume 3 Year 307.46M

Range 10 Year

7.67 50.97

Volume 10 Year 375.91M

Highlights

Market Capitalization 193.83M (small)

Floating Shares 7.6M

Current Price 13.39

Price To Earnings 0.11

Price To Revenue -0.42

Price To Book 1.09

Earnings Per Share 121.66

Payout Ratio 0%

Performance

Latest +1.9%

1 Month -1.83%

3 Months -13%

6 Months +18.81%

1 Year -64.49%

3 Years -42.16%

5 Years -39.41%

10 Years -39.41%

Benchmarks

Market Capitalization

86 / 368

Gross Profits

242 / 278

Total Revenue

254 / 300

Total Rank

325 / 368

Free Cashflow

287 / 352

Performance 5 years

152 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.